This week’s funding landscape is dominated by early-year deadlines and a strong emphasis on pediatric and urologic oncology. The current slate spans mentored summer research programs, trainee travel support, seed-style pilot awards, collaborative multi-institutional grants, and substantial translational mechanisms reaching up to $300,000.
Pediatric oncology features prominently, with tiered translational awards targeting leukemia and solid tumors, legacy funding for sustained pediatric cancer investigators, and short-term trainee grants designed to build the next generation of researchers. Prostate cancer and urologic oncology are equally visible, with multiple CUASF-administered awards, young investigator support, and international training scholarships.
Beyond disease-specific calls, this week includes collaborative research grants, quality-of-life funding in blood cancers, disruptive innovation mechanisms, and consortium-based pilot awards—reinforcing continued investment in both high-risk science and structured career development.
1. CCRF Eliminating Disparities Award in Pediatric Oncology
Funding for projects aimed at reducing disparities in pediatric cancer outcomes. Intended for research teams addressing inequities with measurable oncology impact.
Eligibility Criteria:
-
Project must address pediatric cancer and disparities/inequities.
-
Applicant/institution must meet the award’s eligibility rules in the RFA.
-
LOI and full application materials must follow the RFA requirements.
Funding Details:
-
Amount/range: stated in the CCRF RFA.
-
Funding period and allowable expenses are defined in the RFA.
Deadline:
-
LOI: April 24, 2026.
-
Full application due date: August 10, 2026.
Where to go for further information:
2. Pediatric Cancer Research Foundation Legacy Researcher Oncology Grant 2026
The PCRF Legacy Researcher Grant is designed for long‑standing, PCRF‑funded investigators to sustain and accelerate pediatric cancer research momentum in either basic science or translational work.
Eligibility Criteria:
-
Must have received continuous PCRF funding for at least 5 years.
-
Must show significant milestones and impactful outcomes in pediatric cancer research.
-
Project must be pediatric cancer research (basic science or translational) with demonstrated progress and promise for future breakthroughs.
Funding Details:
-
Translational research: up to $100,000 per year for up to 2 years.
-
Basic science research: up to $150,000 per year, renewable for up to 3 years (based on progress).
Deadline:
-
April 1, 2026.
Where to go for further information:
3. CUASF PROCURE Prostate Cancer Research Grant
Research funding for prostate cancer projects administered via the Canadian Urological Association Scholarship Fund (CUASF) in partnership with PROCURE. Intended for eligible investigators conducting prostate cancer research.
Eligibility Criteria:
-
Proposal must be prostate cancer–focused (oncology).
-
Applicant must meet CUASF/PROCURE eligibility requirements listed in the call.
-
Must follow the posted submission and documentation requirements.
Funding Details:
-
Amount/range: stated in the CUASF/PROCURE call materials.
-
Funding term and allowable costs are defined in the posted guidelines.
Deadline:
- April 1, 2026.
Where to go for further information:
4. CUASF Bayer/CUOG Prostate Cancer Award
Prostate cancer research award administered through CUASF with Bayer and CUOG involvement. Intended for eligible investigators conducting prostate cancer research projects.
Eligibility Criteria:
-
Project must focus on prostate cancer (oncology).
-
Applicant must meet CUASF/Bayer/CUOG eligibility rules specified in the call.
-
Must submit required materials according to the official instructions.
Funding Details:
-
Amount/range: stated in the CUASF call materials.
-
Duration/allowable costs are defined in the posted guidelines.
Deadline:
-
May 15, 2026.
Where to go for further information:
5. SUO Young Urologic Oncologists Research Grant
Seed-style support for early-career urologic oncology research through the Society of Urologic Oncology (YUO). Intended for eligible young investigators building an independent urologic oncology research track.
Eligibility Criteria:
-
Applicant must meet YUO/SUO eligibility requirements for the grant program.
-
Project must be urologic oncology–relevant (cancer focus).
-
Must submit the required application materials by the deadline.
Funding Details:
-
Amount: stated on the official YUO grant page.
-
Award terms/conditions are defined in the posted instructions.
Deadline:
-
March 1, 2026.
Where to go for further information:
6. John Voight Memorial Leukemia Research Grant – Pediatric AML Oncology
A translational pediatric leukemia research grant honoring John Voight, focused on accelerating new treatments for children with leukemia—particularly Acute Myelocytic Leukemia (AML). Structured as a two-tier award totaling up to $300,000 over three years.
Eligibility Criteria:
-
Research must be original, novel, and focused on pediatric leukemia, with emphasis on AML.
-
Applicant must hold an MD, PhD, MD/PhD (or equivalent); postdoctoral researchers are eligible.
-
Institution must be U.S.-based and nonprofit or academic.
Funding Details:
-
Tier 1: $100,000 for 1 year (translational pediatric leukemia research).
-
Tier 2: $200,000 for 2 additional years (awarded to successful Tier 1 recipients).
Deadline:
-
Letter of Intent: July 3, 2026
-
Full Proposal (invited only): October 16, 2026
Where to go for further information:
7. Science Is the Cure Research Grant – Pediatric Oncology
A translational pediatric cancer grant supporting development of promising therapies for blood cancers and solid tumors. Two-step funding mechanism totaling up to $300,000 over two to three years.
Eligibility Criteria:
-
Research must be original and focused on pediatric liquid or solid cancers.
-
Applicant must hold an MD, PhD, MD/PhD (or equivalent); postdoctoral researchers are eligible.
-
Institution must be U.S.-based and nonprofit or academic.
Funding Details:
-
Tier 1: $100,000 for 1 year (translational pediatric oncology research).
-
Tier 2: $100,000–$200,000 for 1–2 additional years (for successful Tier 1 recipients).
Deadline:
-
Letter of Intent: July 3, 2026
-
Full Proposal (invited only): October 16, 2026
Where to go for further information:
8. Emerging Scientist Grant – Pediatric Oncology Trainee Award
A short-term pediatric cancer research award supporting graduate students working under mentorship in pediatric oncology. Designed to expose trainees to pediatric cancer research careers.
Eligibility Criteria:
-
Must be a graduate student (Master’s, PhD, or medical degree) at an accredited institution.
-
Must work directly with a U.S.-based mentor in pediatric cancer research.
-
Research must be applicable to pediatric cancer.
Funding Details:
-
$10,000 total award.
-
Project length: 1–3 months.
Deadline:
-
Full Application Due: July 3, 2026
-
Award Notification: August 14, 2026
Where to go for further information:
9. CUASF Female Pelvic Medicine Research Grant
A research grant supporting clinical, translational, or basic science projects focused on female pelvic floor disorders and female urological conditions, including oncology-related care and quality-of-life studies.
Eligibility Criteria:
-
Principal Investigator must be a CUA member and practicing/training in Canada.
-
PI must be MD or PhD; if non-urologist, urology co-PI required.
-
Project must relate to female pelvic medicine or female urological conditions.
Funding Details:
-
Up to $50,000 per year (anticipated 1 award).
-
Study duration: 12–24 months.
Deadline:
-
March 1, 2026.
Where to go for further information:
-
Contact: marfisa.defrancesco@cua.org.
10. CUASF–SIU International Scholarship Program
An international training scholarship supporting urologists from developing countries seeking hands-on training in Canada or SIU-designated centers, or Canadian urologists training providers abroad.
Eligibility Criteria:
-
Must be a fully trained urologist or trainee from a developing country (IMF B/C country classification) OR Canadian SIU member training abroad.
-
Must provide confirmation of fellowship/training acceptance.
-
Must demonstrate intent to return to home country (if international applicant).
Funding Details:
-
Up to $10,000 per award (maximum $2,000/month).
-
Duration: 1 month to 1 year; awards not renewable.
Deadline:
-
April 1, 2026.
Where to go for further information:
-
Contact: marfisa.defrancesco@cua.org.
Several February deadlines are approaching quickly, particularly for trainee travel, summer studentships, blood cancer quality-of-life research, and collaborative pilot funding. March and April bring a dense cluster of prostate, urologic oncology, and disruptive innovation grants, followed by major pediatric translational mechanisms closing in July.
If you’re planning submissions this quarter, prioritize near-term trainee and pilot mechanisms while mapping larger collaborative or tiered translational proposals well in advance of LOI deadlines.
We’ll continue tracking high-value oncology funding opportunities each week—follow OncoDaily’s OncoGrants series for the next roundup.